A Remote Management Program Improves the Utilization of GDMT in Patients With Type 2 Diabetes at High Cardiovascular and/or Kidney Risk
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Randomized Evaluation of a Remote Management Program to Improve Guideline-directed Medical Therapy: The Diabetes Remote Intervention to Improve Use of Evidence-based Medications (DRIVE) Trial
Circulation 2024 Apr 07;[EPub Ahead of Print], AJ Blood, LS Chang, S Hassan, J Chasse, G Stern, D Gabovitch, D Zelle, C Colling, SJ Aronson, C Figueroa, E Collins, R Ruggiero, E Zacherle, J Noone, C Robar, J Plutzky, TA Gaziano, CP Cannon, DJ Wexler, BM SciricaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.